Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05415878

Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers

Within their lifetime, over 30% of people living with diabetes will develop a diabetic foot ulcer (DFU), many of which will never heal and may require amputation. Removable cast walkers (RCWs) are commonly prescribed to offload (treat) DFUs. While RCWs are prescribed to be worn during all weight bearing activities, adherence to this prescription is low. This is a serious concern given that low adherence predicts poor DFU healing. This study will provide pilot/feasibility data to inform a larger clinical trial to evaluate the impact of existing RCW designs on adherence and DFU healing. We will also quantify the effect of RCW form on biomechanical and self-reported measures related to usability. Our working hypothesis is that healing outcomes with a given RCW will be predicted by biomechanical and self-reported measures of RCW usability, with the predictive relationship partly explained by the effect of these measures on adherence.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rosalind Franklin University of Medicine and Science

North Chicago, Illinois, 60064, United States

Location status: Recruiting

Location contact

Noah J Rosenblat, PhD

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • presence of a full thickness plantar (forefoot) diabetic foot ulcer ≥1cm2 that is being treated on an outpatient basis with a University of Texas wound classification of 1A-C or 2 A-C;
  • self-reported ability to walk for at least two continuous minutes at a self-selected speed
  • confirmation of the presence of diabetic peripheral neuropathy as identified by failure to detect a 10 gram Semmes Weinstein Monofilament on either foot at one of four sites tested (1st, 3rd, 5th metatarsal heads, and plantar surface of hallux) OR a vibration perception threshold value of 25 or more at either hallux.

Exclusion criteria

  • lower extremity amputation more proximal than transmetatarsal on either limb
  • chronic kidney disease stage 4 or higher (i.e., currently undergoing dialysis or eGFR<30 within last 60 days)
  • active Charcot neuroarthropathy
  • severe peripheral arterial disease (non-palpable pulse at posterior tibia and dorsalis pedis arteries, and an ankle brachial index<0.7)
  • gait/balance disturbance not attributable to diabetes (e.g. neuromuscular disease or cerebrovascular vascular accident)
  • current or previous (within past year) use of an ankle-high RCW or of a contralateral lift to offset an RCW-induced LLD

Treatment and study plan

RCW design form

Device

Tall RCW= a knee high removable cast walker with an offloading insole

Short RCW= an ankle high (extending up the leg just past the ankle) removable cast walker with an offloading insole, paired with an external shoe lift to be used with a diabetic shoe on the contralateral limb

Primary outcomes

  1. Offloading adherence

    Time frame: days 0-28

    Percent of weight bearing activity completed while wearing the RCW

Secondary outcomes

  1. Diabetic Foot Ulcer Healing

    Time frame: each clinical visit during days 0-28

    Planimetric wound area

  2. Cumulative plantar tissue stress

    Time frame: days 0-28

    A measure to account for the interaction between offloading capacity of the RCW and device use

Other outcomes

  1. Stability

    Time frame: follow up visit (32-38 days after baseline)

    three separate measures taken during walking and standing (local divergence exponent of he trunk; motor equivalent index during small standing perturbations; and posterior stepping threshold for large perturbations while standing)

  2. Correlates of joint pain

    Time frame: follow up visit (32-38 days after baseline)

    Four separate biomechanical measures related to back, hip and knee pain taken during walking in a motion capture lab (peak pelvic obliquity; peak pelvic tilt; ground reaction force transience; and rate of grand reaction force loading)

Study contacts

Contact information is provided by the study sponsor or research team.

Noah J Rosenblatt, PhD

CONTACT

[email protected]

8475788425

Ryan Crews, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Rosalind Franklin University of Medicine and Science

Other

Collaborators

  • Manchester Metropolitan University

Registry information

Official study title

Improving Diabetic Foot Ulcer Offloading: A Pilot Study on the Impact of Removable Cast Walker Design Factors on Usability

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Jun 13, 2022
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.